← FDA Drug Approvals (Drugs@FDA)
DECITABINE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: HETERO LABS LTD VI · Approved 2024-05-10
Drug application
- FDA Application #
ANDA215355- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- DECITABINE
- Generic name
- DECITABINE
- Active ingredients
- DECITABINE
- Dosage form
- INJECTABLE
- Route
- INTRAVENOUS
- Marketing status
- Prescription
- Sponsor
- HETERO LABS LTD VI
- Manufacturer
- BluePoint Laboratories
- First approval
- 2024-05-10
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown